Creo Medical Group Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	12.4	8.7	3	13.1	43.53
Short-Term Investments	-	-	15.5	-	-
Cash & Short-Term Investments	12.4	8.7	18.5	13.1	43.53
Cash Growth	42.53%	-52.97%	41.22%	-69.91%	-3.45%
Accounts Receivable	5.6	1.3	7.8	5	3.88
Other Receivables	1.3	2.4	2.8	5.2	4.88
Receivables	6.9	3.7	10.6	10.2	8.76
Inventory	2.5	2.7	8.1	9.3	8.5
Prepaid Expenses	-	0.4	0.7	1.1	0.37
Other Current Assets	1.7	40.9	-	-	-
Total Current Assets	23.5	56.4	37.9	33.7	61.17
Property, Plant & Equipment	3.4	5.9	9.1	9.7	8.6
Long-Term Investments	30.9	2.1	2.1	2.6	1.73
Goodwill	-	-	19.1	19.6	18.56
Other Intangible Assets	1.3	0.3	6.8	7.8	8.33
Long-Term Deferred Tax Assets	-	-	1.1	1.5	1.71
Long-Term Deferred Charges	-	0.2	0.3	0.2	0.36
Other Long-Term Assets	-	0.1	0.2	0.1	0.15
Total Assets	59.1	65	76.6	75.2	100.61
Accounts Payable	4.9	0.9	5.7	4.3	3.54
Accrued Expenses	-	2.9	-	4.1	5.18
Short-Term Debt	2.3	-	2	3.8	3.32
Current Portion of Long-Term Debt	-	2.2	0.5	1.2	1.39
Current Portion of Leases	-	0.2	0.6	0.6	0.67
Current Unearned Revenue	-	0.1	-	-	-
Other Current Liabilities	0.1	14.2	1.1	3.4	5.63
Total Current Liabilities	7.3	20.5	9.9	17.4	19.74
Long-Term Debt	1.8	1.9	4.4	4.9	3.79
Long-Term Leases	-	0.1	0.8	1.2	1.39
Long-Term Deferred Tax Liabilities	-	-	1.4	2	1.79
Other Long-Term Liabilities	-	0.1	0.3	0.4	0.59
Total Liabilities	9.1	22.6	16.8	25.9	27.29
Common Stock	0.4	0.4	0.4	0.2	0.18
Additional Paid-In Capital	191.9	192	180.9	149.5	149.45
Retained Earnings	-167.4	-173.1	-144.4	-122.7	-95.76
Comprehensive Income & Other	25.1	23.1	22.9	22.3	19.45
Total Common Equity	50	42.4	59.8	49.3	73.32
Shareholders' Equity	50	42.4	59.8	49.3	73.32
Total Liabilities & Equity	59.1	65	76.6	75.2	100.61
Total Debt	4.1	4.4	8.3	11.7	10.56
Net Cash (Debt)	8.3	4.3	10.2	1.4	32.98
Net Cash Growth	93.02%	-57.84%	628.57%	-95.75%	0.74%
Net Cash Per Share	0.02	0.01	0.03	0.01	0.20
Filing Date Shares Outstanding	530	402.15	351.25	181.38	178.1
Total Common Shares Outstanding	530	402.15	351.25	181.38	178.1
Working Capital	16.2	35.9	28	16.3	41.43
Book Value Per Share	0.09	0.11	0.17	0.27	0.41
Tangible Book Value	48.7	42.1	33.9	21.9	46.42
Tangible Book Value Per Share	0.09	0.10	0.10	0.12	0.26
Land	-	4.6	4.6	4.6	4.51
Machinery	-	4.3	6.8	6	5.11
Construction In Progress	-	0.1	0.1	1.4	0.15
Leasehold Improvements	-	2.3	2.6	0.9	0.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.